Skip to content

Effect of transcutaneous auricular vagus nerve stimulation on postoperative pain and quality of recovery in patients undergoing laparoscopic cholecystectomy: a single-centre, prospective, randomised, double-blind, controlled study

Effect of transcutaneous auricular vagus nerve stimulation on postoperative pain and quality of recovery in patients undergoing laparoscopic cholecystectomy: a single-centre, prospective, randomised, double-blind, controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068410
Enrollment
Unknown
Registered
2023-02-17
Start date
2024-05-13
Completion date
Unknown
Last updated
2025-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain

Interventions

Test group:Stimulator treatment site placed in the ear nail boat area
Control group:stimulator treatment area is placed in the earlobe area

Sponsors

Huzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. ASA Class I to II; 2. Aged 25 to 65 years; 3. First laparoscopic gallbladder surgery; 4. Subjects voluntarily participated in the study and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Skin of patients appearing broken and exhibiting redness, swelling, and signs of infection at the site of taVNS; 2. Patients with preexisting tinnitus and arrhythmia prior to surgery; 3. Patients with implanted medical devices, such as cardiac pacemakers; 4. History of previous major abdominal surgery; 5. Patients with a history of chronic pain, neuropathic pain, long-term use of analgesics or other psychotropic medications; 6. Body mass index (BMI) > 35 kg/m2; 7. Patients with comorbidities of psychiatric and neurological disorders, infectious diseases, severe cardiovascular and cerebrovascular diseases, hepatic and renal dysfunction, as well as hematopoietic system diseases; 8. Disinclining to participate or being unable to complete the trial plan.

Design outcomes

Primary

MeasureTime frame
NRS pain score;

Secondary

MeasureTime frame
15-item Quality of Recovery Score (QOR15 scale);Depression scores (SDS scale);Pittsburgh Sleep Quality Index (PSQI scale); Postoperative nausea and vomiting score (PONV scale);NRS pain score;

Countries

China

Contacts

Public ContactZhang Qin

Huzhou Central Hospital

18895339778@163.com+86 188 9533 9778

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026